These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 20494936)

  • 21. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
    Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
    Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A distinct set of long non-coding RNAs in childhood MLL-rearranged acute lymphoblastic leukemia: biology and epigenetic target.
    Fang K; Han BW; Chen ZH; Lin KY; Zeng CW; Li XJ; Li JH; Luo XQ; Chen YQ
    Hum Mol Genet; 2014 Jun; 23(12):3278-88. PubMed ID: 24488769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
    van der Linden MH; Seslija L; Schneider P; Driessen EM; Castro PG; Stumpel DJ; van Roon E; de Boer J; Williams O; Pieters R; Stam RW
    PLoS One; 2015; 10(3):e0120326. PubMed ID: 25793396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia.
    Zhang H; Liu B; Cheng J; Ma H; Li Z; Xi Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.
    Chen P; Price C; Li Z; Li Y; Cao D; Wiley A; He C; Gurbuxani S; Kunjamma RB; Huang H; Jiang X; Arnovitz S; Xu M; Hong GM; Elkahloun AG; Neilly MB; Wunderlich M; Larson RA; Le Beau MM; Mulloy JC; Liu PP; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11511-6. PubMed ID: 23798388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for targeting BCL6 in
    Hurtz C; Chan LN; Geng H; Ballabio E; Xiao G; Deb G; Khoury H; Chen CW; Armstrong SA; Chen J; Ernst P; Melnick A; Milne T; Müschen M
    Genes Dev; 2019 Sep; 33(17-18):1265-1279. PubMed ID: 31395741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
    Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
    Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; van Grotel M; Tchinda J; Lee C; Beverloo HB; van der Spek PJ; Stubbs A; Cools J; Nagata K; Fornerod M; Buijs-Gladdines J; Horstmann M; van Wering ER; Soulier J; Pieters R; Meijerink JP
    Blood; 2008 May; 111(9):4668-80. PubMed ID: 18299449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
    Danen-van Oorschot AA; Kuipers JE; Arentsen-Peters S; Schotte D; de Haas V; Trka J; Baruchel A; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2012 May; 58(5):715-21. PubMed ID: 21818844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia.
    Mata JF; Scrideli CA; Queiroz RP; Mori BO; Emerenciano M; Pombo-de-Oliveira MS; Tone LG
    Braz J Med Biol Res; 2006 Nov; 39(11):1417-23. PubMed ID: 17146554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL).
    Soulier J; Clappier E; Cayuela JM; Regnault A; García-Peydró M; Dombret H; Baruchel A; Toribio ML; Sigaux F
    Blood; 2005 Jul; 106(1):274-86. PubMed ID: 15774621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
    Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs mark in the MLL-rearranged leukemia.
    Benetatos L; Vartholomatos G
    Ann Hematol; 2013 Nov; 92(11):1439-50. PubMed ID: 23728610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
    Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOXA9 is required for survival in human MLL-rearranged acute leukemias.
    Faber J; Krivtsov AV; Stubbs MC; Wright R; Davis TN; van den Heuvel-Eibrink M; Zwaan CM; Kung AL; Armstrong SA
    Blood; 2009 Mar; 113(11):2375-85. PubMed ID: 19056693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants.
    Stam RW; Schneider P; Hagelstein JA; van der Linden MH; Stumpel DJ; de Menezes RX; de Lorenzo P; Valsecchi MG; Pieters R
    Blood; 2010 Apr; 115(14):2835-44. PubMed ID: 20032505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.
    Juszczynski P; Rodig SJ; Ouyang J; O'Donnell E; Takeyama K; Mlynarski W; Mycko K; Szczepanski T; Gaworczyk A; Krivtsov A; Faber J; Sinha AU; Rabinovich GA; Armstrong SA; Kutok JL; Shipp MA
    Clin Cancer Res; 2010 Apr; 16(7):2122-30. PubMed ID: 20332322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.